The risks involved in medical tourism aren't just personal. Having surgery abroad could also mean bringing back a drug-resistant superbug and putting people in the patient’s home country at risk, Canadian officials warn.
Recent testing showed the organism infecting the patient, an Enterobacteriaceae, also included a rare antibiotic-resistant gene known as MCR-1. It does not appear the infection was acquired at the hospital.
Plumbing systems are an infrequent but known reservoir for opportunistic microbial pathogens that can infect hospitalized patients. In 2016, a cluster of clinical sphingomonas infections prompted an investigation.
Scientists from the Qingdao Institute of Bioenergy and Bioprocess Technology (QIBEBT) have introduced a prototype instrument that can directly measure antimicrobial resistant phenotypes at single-cell resolution from clinical samples within three hours, without the need for cell propagation.
Researchers sequenced whole genomes of superbugs from a large sample of different animals as well as humans to study the DNA changes that helped the bacteria to adapt to new host organisms during thousands of years.
The antibiotics (odilorhabdin) are produced by symbiotic bacteria found in soil-dwelling nematode worms that colonize insects for food.
Researchers identified two synthetic retinoids, both of which demonstrated the ability to kill methicillin-resistant Staphylococcus aureus (MRSA).
Researchers also found that the share of bacterial infections in the US that were antibiotic resistant more than doubled over 13 years.
This report draws information from Global Antimicrobial Resistance Surveillance System (GLASS) enrolled countries on the status of their antimicrobial resistance (AMR) surveillance systems, and reports official national AMR data for selected bacteria that cause infections in humans: Acinetobacter spp., Escherichia coli, Klebsiella pneumoniae, Neisseria gonorrhoeae, Salmonella spp., Shigella spp., Staphylococcus aureus, and Streptococcus pneumoniae.
The Global Antimicrobial Resistance Surveillance System (GLASS) seeks to support the global action plan on antimicrobial resistance. The aim is to support global surveillance and research to strengthen the evidence base on antimicrobial resistance (AMR) and help informing decision-making and drive national, regional, and global actions.